MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-04-0047081
Kiyaan Pharmaceuticals Private Limited
Kiyaan Pharmaceuticals Private Limited - trading in Aurangabad, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹54,579
▼ 86% YoY
Net loss · FY 2025
₹1.52 Lakh
Net margin -278.2%
EBITDA · FY 2025
-₹1.46 Lakh
EBITDA margin -268.2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Kiyaan Pharmaceuticals Private Limited
Data last updated:
Kiyaan Pharmaceuticals Private Limited is a private limited company based in Aurangabad, Maharashtra, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 29 September 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2021PTC368398. Its GSTIN is 27AAJCK0508K1ZH (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Aditya Vijay Jadhav and Vijaybhai Bodar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Kasliwal Vihar Flat No. E – 1/4 Pratapnagar, Aurangabad, Maharashtra, India – 431001.
As per the financials filed for FY 2025, the company reported a revenue of ₹54,579, a decline of 86% compared to the previous year. For the same year it recorded a net loss of ₹1.52 Lakh (net margin -278.2%) and EBITDA of -₹1.46 Lakh (EBITDA margin -268.2%). Revenue has declined at a compounded annual rate (CAGR) of 55% over three years.
Kiyaan Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-04-0047081).
Company details
CIN U51909MH2021PTC368398
Registration Number 368398
Incorporation Date 29 September 2021
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-04-0047081
Recognitions & Rankings of Kiyaan Pharmaceuticals
Contact details
Kiyaan Pharmaceuticals Private Limited's registered office is in Aurangabad, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressKasliwal Vihar Flat No. E – 1/4 Pratapnagar, Aurangabad, Maharashtra, India – 431001
- IndustryTrading, Specialty, Wholesale
To see the full contact details of Kiyaan Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Kiyaan Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Kiyaan Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Kiyaan Pharmaceuticals Private Limited, buy the company report.
Financials of Kiyaan Pharmaceuticals Private Limited
FY 2025 filings availableKiyaan Pharmaceuticals Private Limited reported revenue of ₹54,579 (down 86% YoY) for FY 2025.
Revenue · FY 2025
₹54,579 ▼ 86%
Net loss · FY 2025
₹1.52 Lakh margin -278.2%
EBITDA · FY 2025
-₹1.46 Lakh margin -268.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 86%
3 years · compounded
▼ 55%
EBITDA CAGR growth
3 years · compounded
▼ 146%
Revenue has declined at a compounded annual rate (CAGR) of 55% over three years, including a 86% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹1.46 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹1.52 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -268.2% | |||
| Net Profit Margin | -278.2% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Kiyaan Pharmaceuticals Private Limited, buy the company report.
Board of directors of Kiyaan Pharmaceuticals Private Limited
Kiyaan Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vijaybhai Bodar | Additional Director | 04 Nov 2025 | 1 Years 0 Months | Current |
| Aditya Vijay Jadhav | Director | 25 Nov 2025 | 0 Years 11 Months | Current |
Legal cases
No court or tribunal cases involving Kiyaan Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kiyaan Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Kiyaan Pharmaceuticals Private Limited has 1 active EPFO establishment as of Mar 29, 2024.
Active EPFO establishments
1
GST
Kiyaan Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAJCK0508K1ZH | Maharashtra | Active | 04 Nov 2021 |
To see the full GST registrations and return filing status of Kiyaan Pharmaceuticals Private Limited, buy the company report.
Recent activity
Kiyaan Pharmaceuticals Private Limited has 7 board changes on record since 2021: 4 appointments and 3 cessations. The latest: Aditya Vijay Jadhav was appointed as Director on 25 Nov 2025.
Appointed
Aditya Vijay Jadhav was appointed as Director.
Ceased
Hemant Prabhakar Suryawanshi ceased to be Director.
Appointed
Vijaybhai Bodar was appointed as Additional Director.
AGM
Kiyaan Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Kiyaan Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Ceased
Kaveri Prashant Patil ceased to be Additional Director.
Appointed
Kaveri Prashant Patil was appointed as Director.
Ceased
Prashant Sahebrao Patil ceased to be Director.
Appointed
Hemant Prabhakar Suryawanshi was appointed as Director.
Incorporation
29 Sep 2021
Kiyaan Pharmaceuticals Private Limited was registered on 29 Sep 2021 with Roc Mumbai Ii & aged 5 years 1 month as per MCA records.
Frequently asked questions
Kiyaan Pharmaceuticals is an active private limited company based in Aurangabad, Maharashtra, India. The company works in specialty, within the trading industry. It was incorporated on 29 September 2021 (5+ years old) and is registered under CIN U51909MH2021PTC368398.
Kiyaan Pharmaceuticals has 2 current directors:
- Vijaybhai Bodar - Additional Director
- Aditya Vijay Jadhav - Director
The latest financial statements of Kiyaan Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Kiyaan Pharmaceuticals is 27AAJCK0508K1ZH, registered in Maharashtra.
The CIN (Corporate Identification Number) of Kiyaan Pharmaceuticals is U51909MH2021PTC368398. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kiyaan Pharmaceuticals was incorporated on 29 September 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.
Aditya Vijay Jadhav was appointed as Director on 25 Nov 2025. Hemant Prabhakar Suryawanshi ceased to be Director on 25 Nov 2025. Vijaybhai Bodar was appointed as Additional Director on 04 Nov 2025. Kiyaan Pharmaceuticals has 7 board changes on record in total.
Yes, Kiyaan Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-04-0047081).
The registered office of Kiyaan Pharmaceuticals is at Kasliwal Vihar Flat No. E – 14 Pratapnagar, Aurangabad, Maharashtra, India – 431001.
Kiyaan Pharmaceuticals operates in the trading industry, in the specialty segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages